• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种辉瑞-BioNTech BNT162b2疫苗后脸颊出现扁平疣:是否存在关联?

Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation?

作者信息

Cazzato Gerardo, Romita Paolo, Foti Caterina, Lobreglio Debora, Trilli Irma, Colagrande Anna, Ingravallo Giuseppe, Resta Leonardo

机构信息

Section of Molecular Pathology, Department of Emergency and Organ Tranplantation (DETO), University of Bari "Aldo Moro", 70124 Bari, Italy.

Section of Dermatology and Venereology, Department of Biomedical Sciences and Oncology (DIMO), University of Bari "Aldo Moro", 70124 Bari, Italy.

出版信息

Vaccines (Basel). 2022 Mar 29;10(4):532. doi: 10.3390/vaccines10040532.

DOI:10.3390/vaccines10040532
PMID:35455281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9032489/
Abstract

The SARS-CoV-2 pandemic has affected health systems across the globe, making the use of vaccines more urgent and topical than ever. Since the first months after the introduction of vaccinations, several reactions, both local and systemic, have been reported although they were mostly very mild and only rarely harbingers of more serious complications. We present a case of multiple flat warts onset over the cheeks in a patient after the second dose of mRNA BioNTech-Pfizer BNT162b2 vaccine, and we discuss the possible temporal association between the two events, also considering the patient's antibody status.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行已影响全球卫生系统,使得疫苗的使用比以往任何时候都更加紧迫和热门。自接种疫苗后的头几个月以来,已报告了几种局部和全身反应,尽管大多数反应非常轻微,很少预示着更严重的并发症。我们报告了1例患者在接种第二剂mRNA 辉瑞-BioNTech BNT162b2疫苗后脸颊出现多发性扁平疣的病例,并讨论了这两个事件之间可能的时间关联,同时也考虑了患者的抗体状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f4/9032489/eb9851f3d6fc/vaccines-10-00532-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f4/9032489/b9bd0bc26197/vaccines-10-00532-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f4/9032489/eb9851f3d6fc/vaccines-10-00532-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f4/9032489/b9bd0bc26197/vaccines-10-00532-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11f4/9032489/eb9851f3d6fc/vaccines-10-00532-g002.jpg

相似文献

1
Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation?接种辉瑞-BioNTech BNT162b2疫苗后脸颊出现扁平疣:是否存在关联?
Vaccines (Basel). 2022 Mar 29;10(4):532. doi: 10.3390/vaccines10040532.
2
Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.一种自我扩增 RNA COVID-19 疫苗(ARCT-154)与 BNT162b2 mRNA COVID-19 疫苗加强针的免疫原性和安全性:一项双盲、多中心、随机、对照、3 期、非劣效性试验。
Lancet Infect Dis. 2024 Apr;24(4):351-360. doi: 10.1016/S1473-3099(23)00650-3. Epub 2023 Dec 20.
3
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗:辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
4
Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.第二剂mRNA(辉瑞-生物科技公司)新冠疫苗接种后发生大疱性类天疱疮:一例报告。
Ann Med Surg (Lond). 2022 Mar;75:103420. doi: 10.1016/j.amsu.2022.103420. Epub 2022 Mar 1.
5
Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine.广泛性丘疹水疱疹作为辉瑞-生物科技公司新冠疫苗的一种副作用
Cureus. 2022 Feb 20;14(2):e22414. doi: 10.7759/cureus.22414. eCollection 2022 Feb.
6
Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.波兰医护人员中新冠疫苗的安全性概况
Vaccines (Basel). 2022 Mar 12;10(3):434. doi: 10.3390/vaccines10030434.
7
[Comparative Analyses of IgA Antibody Response of Non-COVID-19 Infected People Over 60 Years Old Following CoronaVac and Pfizer-BioNTech COVID-19 Vaccination].60岁以上未感染新冠病毒人群接种科兴新冠疫苗和辉瑞-BioNTech新冠疫苗后IgA抗体反应的比较分析
Mikrobiyol Bul. 2023 Apr;57(2):330-333. doi: 10.5578/mb.20239927.
8
Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis.接种新冠疫苗后出现的葡萄膜炎:疫苗不良事件报告系统数据库分析。
Ophthalmology. 2023 Feb;130(2):179-186. doi: 10.1016/j.ophtha.2022.08.027. Epub 2022 Aug 31.
9
Increasing Levels of Serum Anti-Spike S1-RBD IgG after 120 Days of the Pfizer-BioNTech-mRNA Second Dose Vaccination.辉瑞-生物科技 mRNA 疫苗第二剂接种 120 天后血清抗刺突 S1-RBD IgG 水平升高。
Arch Razi Inst. 2023 Jun 30;78(3):1071-1075. doi: 10.22092/ARI.2022.359934.2517. eCollection 2023 Jun.
10
Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12-17 Years against COVID-19 Infection in Qatar.辉瑞-生物科技mRNA疫苗对卡塔尔12至17岁儿童和青少年预防新冠病毒感染的效果
Vaccines (Basel). 2023 Sep 25;11(10):1522. doi: 10.3390/vaccines11101522.

引用本文的文献

1
Broad-Spectrum Adverse Events of Special Interests Based on Immune Response Following COVID-19 Vaccination: A Large-Scale Population-Based Cohort Study.基于新冠病毒疫苗接种后免疫反应的特殊关注的广谱不良事件:一项基于大规模人群的队列研究
J Clin Med. 2025 Mar 6;14(5):1767. doi: 10.3390/jcm14051767.
2
Cutaneous Manifestations of SARS-CoV-2, Cutaneous Adverse Reactions to Vaccines Anti-SARS-CoV-2 and Clinical/Dermoscopical Findings: Where We Are and Where We Will Go.新型冠状病毒2型(SARS-CoV-2)的皮肤表现、抗SARS-CoV-2疫苗的皮肤不良反应以及临床/皮肤镜检查结果:我们所处的位置以及未来的方向
Vaccines (Basel). 2023 Jan 10;11(1):152. doi: 10.3390/vaccines11010152.
3

本文引用的文献

1
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines.新型 COVID-19 变种及其对 SARS-CoV-2 诊断、治疗和疫苗的影响。
Ann Med. 2022 Dec;54(1):524-540. doi: 10.1080/07853890.2022.2031274.
2
SARS-CoV-2 Variants, Vaccines, and Host Immunity.SARS-CoV-2 变体、疫苗和宿主免疫。
Front Immunol. 2022 Jan 3;12:809244. doi: 10.3389/fimmu.2021.809244. eCollection 2021.
3
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.基于信使核糖核酸的新冠病毒疫苗加强针可诱导针对严重急性呼吸综合征冠状病毒2奥密克戎变种的中和免疫力。
Correlation between Clinical and Immunological Variables and Humoral Response to SARS-CoV-2 Vaccination in Adult Patients with Antibody Deficiency Disorders.
抗体缺乏症成年患者的临床与免疫变量及对SARS-CoV-2疫苗接种的体液反应之间的相关性
Pathogens. 2022 Nov 16;11(11):1364. doi: 10.3390/pathogens11111364.
Cell. 2022 Feb 3;185(3):457-466.e4. doi: 10.1016/j.cell.2021.12.033. Epub 2022 Jan 6.
4
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact.接种疫苗人群中的 SARS-CoV-2 突破感染:测量、原因和影响。
Nat Rev Immunol. 2022 Jan;22(1):57-65. doi: 10.1038/s41577-021-00662-4. Epub 2021 Dec 7.
5
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines.与SARS-CoV-2疫苗相关的皮肤不良反应
J Clin Med. 2021 Nov 16;10(22):5344. doi: 10.3390/jcm10225344.
6
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.5至11岁儿童中BNT162b2新冠疫苗的评估
N Engl J Med. 2022 Jan 6;386(1):35-46. doi: 10.1056/NEJMoa2116298. Epub 2021 Nov 9.
7
Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review.新型冠状病毒疫苗随机试验中活性组和安慰剂组的不良事件:一项系统评价。
Lancet Reg Health Eur. 2022 Jan;12:100253. doi: 10.1016/j.lanepe.2021.100253. Epub 2021 Oct 28.
8
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.比较 COVID-19 疫苗在针对 SARS-CoV-2 及其关注变异株的特性、疗效和有效性方面的差异:一项叙述性综述。
Clin Microbiol Infect. 2022 Feb;28(2):202-221. doi: 10.1016/j.cmi.2021.10.005. Epub 2021 Oct 27.
9
Actions and attitudes on the immunized patients against SARS-CoV-2.针对 SARS-CoV-2 免疫患者的行动和态度。
Rev Esp Quimioter. 2022 Feb;35(1):7-15. doi: 10.37201/req/131.2021. Epub 2021 Oct 21.
10
Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis.特应性皮炎与自身免疫性疾病风险:一项系统评价与荟萃分析。
Allergy Asthma Clin Immunol. 2021 Sep 25;17(1):96. doi: 10.1186/s13223-021-00597-4.